Individuals with insulin resistance and difficult-to-control sugars may also receive a different medication as part of their treatment plan, such as metformin or NovoLog (insulin aspart)
Nevertheless, other conceptual and methodological differences may explain discrepancies in results between genetically informed (capturing average lifetime risk and etiological mechanisms) and observational (capturing time specific or acute events and disease progression) analyses
After one year, patients switching from Wegovy maintained about 82% of their prior weight loss, while patients switching from Zepbound maintained about 78%
USA 113 (22), e3130e3139
HUBERMAN: While I'm not opposed to that approach, you just want to make sure that the dosing, or I should say the relative dosing of each peptide is such that, you know, You're avoiding unnecessary increases in prolactin and cortisol, and that you're not hitting a pathway redundantly
Review this information before your trip